Business Context and Reporting Period
Company: Bone Biologics Corp
Filing Type: Form 8-K (Current Report)
Date of Report: July 24, 2017
Reporting Period: Single event date (July 24, 2017)
Business Context: The Company is an emerging growth company incorporated in Delaware. This filing reports a potential capital raise event.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
Item 8.01 (Other Events): The Company announced a possible private placement of its securities. This announcement was made via a press release issued on July 24, 2017, pursuant to Rule 135c under the Securities Act of 1933. No other material changes to operations or financial status are detailed in this specific filing.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) regarding the potential private placement but does not include specific guidance, outlook, or detailed management commentary within the body of the 8-K text.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the inherent uncertainty of a "possible" private placement.
Investor Verification Checklist
- Verify the terms and status of the "possible private placement" by reviewing the attached Press Release (Exhibit 99.1).
- Confirm if the private placement was ultimately executed or abandoned by checking subsequent filings.
- Review the Company's most recent 10-K or 10-Q for actual financial metrics, as this 8-K contains none.
- Assess the impact of the Company's "emerging growth company" status on financial reporting standards.